<DOC>
	<DOCNO>NCT01969071</DOCNO>
	<brief_summary>The effect levosimendan renal function patient low ejection fraction undergo mitral valve surgery investigate prospective , double-blinded , randomized clinical trial use serum creatinine ( sCr ) milligram deciliter ( mg/dL ) value , calculate estimate glomerular filtration ( eGFR ) ( ml/min/1.73 m2 ) rate perioperative clinical follow-up parameter .</brief_summary>
	<brief_title>The Effects Levosimendan During Mitral Valve Surgery</brief_title>
	<detailed_description>Introduction : The coronary peripheral vasodilatory property levosimendan recently investigate patient heart failure . It consider promising alternative conventional inotropic agent patient low LVEF . However , effect levosimendan renal function patient undergo open heart surgery CPB well study randomized clinical trial . The primary goal study investigate effect levosimendan 1- renal function evaluation serum creatinine ( mg/dL ) value calculate estimate glomerular filtration ( eGFR ) ( ml/min/1.73 m2 ) rate . Our secondary goal determine clinical outcome include ; 1-need renal replacement therapy ( RRT ) patient low ejection fraction undergo mitral valve repair replacement surgery cardiopulmonary bypass ( CPB ) . Inclusion exclusion criterion include list . Patients include study diagnosis mitral valve insufficiency without coronary artery disease leave ventricular ejection fraction ( LVEF ) ≤ 45 % . Exclusion criterion unstable angina , diabetes mellitus treat insulin , clinical finding acute chronic renal failure ( serum creatinine ( sCr ) &gt; 1.5 mg/dL ) , severe hepatic disease ( alanine aminotransferase aspartate aminotransferase &gt; 100 U litre/L ) , severe chronic obstructive pulmonary disease ( force expire volume 1 &lt; 50 % predict &lt; 2.0 litre ) , history prior coronary artery bypass graft ( CABG ) surgery myocardial infarction ( MI ) within previous month , emergent operation , patient inotropic support operation , aortic valvular disease , infective endocarditis . The study protocol : The patient randomize two group . Randomization two group perform use seal envelope sequentially number assignment participant conceal envelope open anesthesia induction health care personnel . The observer blind inotropic protocol . Caregivers blind , participate data collection data interpretation . In levosimendan group , load levosimendan ( 6 μg/kg ) administer removal aortic cross-clamp , follow infusion levosimendan dose 0.1 μg/kg/min addition standard inotropic therapy ( one agent include ; dobutamine , epinephrine norepinephrine ) 24 hour . In control group , standard inotropic therapy administer . The need renal replacement therapy ( RRT ) provide patient follow criterion : 1- urine output le 100 mL within last 8 hour , 2- response 50 mg intravenous dose furosemide , 3- urine sodium concentration &gt; 40 milliequivalent/liter ( mEq/L ) administration furosemide , 4- blood urea nitrogen ( BUN ) level &gt; 50 mg/dl 5-additional presence one follow factor ; a- increase serum creatinine level &gt; 50 % preoperative value , b- presence metabolic acidosis , c- presence hypervolemia , d- presence hyperkalemia ( potassium ion level &gt; 5 Meq/L ) . The study parameter : The demographic data include ; age , weight , height , body mass index gender . The cardiovascular risk factor include ; diabetes mellitus , hypertension , hypercholesterolemia , obesity , history smoking well history chronic obstructive pulmonary disease peripheral vascular disease seek . Echocardiographic data perform evaluate ejection fraction valvular function cardiologist use Vivid 3 echocardiography device ( Healthcare General Electronics , Hamburg , Germany ) operation first hour , 12 24 hour operation . Pulmonary hypertension ( PH ) define mean pulmonary artery pressure ( MPAP ) &gt; 25 mmHg rest . The diagnosis PH depend direct measurement mean PAP right heart catheterization . However , use Doppler echocardiographic study provide estimate pulmonary artery systolic pressure ( PASP ) mean PAP calculate formula : mean PAP = 0.65 PASP + 0.55 mmHg . The risk operation evaluate use European System Cardiac Operation Risk Evaluation scale ( EuroSCORE ) . Acute kidney injury ( AKI ) define increase serum creatinine baseline &gt; 50 % within 48 hour postoperatively . SCr level collect preoperative postoperative day 1 , 3 10 eGFR calculate accord abbreviate Modification Diet Renal Disease ( MDRD ) equation .</detailed_description>
	<mesh_term>Mitral Valve Stenosis</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>diagnosis mitral valve insufficiency without coronary artery disease LVEF ≤ 45 % . Exclusion criterion : unstable angina , diabetes mellitus treat insulin , clinical finding acute chronic renal failure ( sCr &gt; 1.5 mg dL1 ) , severe hepatic disease ( alanine aminotransferase aspartate aminotransferase &gt; 100 U litre L1 ) , severe chronic obstructive pulmonary disease ( force expire volume 1 &lt; 50 % predict &lt; 2.0 litre ) , history prior CABG surgery myocardial infarction ( MI ) within previous month , emergent operation , patient inotropic support operation , aortic valvular disease , infective endocarditis .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>levosimendan</keyword>
	<keyword>mitral valve surgery</keyword>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>serum creatinine</keyword>
	<keyword>estimate glomerular filtration rate</keyword>
	<keyword>ejection fraction</keyword>
</DOC>